Key result
Systemic hypertension alters the expression profiles of arterial voltage-gated calcium and potassium channels, offering potential new targets for the development of vasoactive drugs.
Understanding disease-specific changes in arterial ion channel expression during hypertension may provide new targets for the development of novel vasoactive drugs.
Answers are grounded in this paper and cite their sources.
May guide ion channel-targeted drug development in hypertension; leaves open clinical translation pending prospective trials.
The diameters of small arteries and arterioles are tightly regulated by the dynamic interaction between Ca(2+) and K(+) channels in the vascular smooth muscle cells. Calcium influx through voltage-gated Ca(2+) channels induces vasoconstriction, whereas the opening of K(+) channels mediates hyperpolarization, inactivation of voltage-gated Ca(2+) channels, and vasodilation. Three types of voltage-sensitive ion channels have been highly implicated in the regulation of resting vascular tone. These include the L-type Ca(2+) (Ca(L)) channels, voltage-gated K(+) (K(V)) channels, and high-conductance voltage- and Ca(2+)-sensitive K(+) (BK(Ca)) channels. Recently, abnormal expression profiles of these ion channels have been identified as part of the pathogenesis of arterial hypertension and other vasospastic diseases. An increasing number of studies suggest that high blood pressure may trigger cellular signaling cascades that dynamically alter the expression profile of arterial ion channels to further modify vascular tone. This article will briefly review the properties of Ca(L), K(V), and BK(Ca) channels, present evidence that their expression profile is altered during systemic hypertension, and suggest potential mechanisms by which the signal of elevated blood pressure may result in altered ion channel expression. A final section will discuss emerging concepts and opportunities for the development of new vasoactive drugs, which may rely on targeting disease-specific changes in ion channel expression as a mechanism to lower vascular tone during hypertensive diseases.
No takes yet. Share an insight, caveat, or question.
Cox et al. (2002) conducted a review in Systemic hypertension. Systemic hypertension alters the expression profiles of arterial voltage-gated calcium and potassium channels, offering potential new targets for the development of vasoactive drugs.
Synapse has enriched 10 related papers. Consider them for comparative context: